For the Inventor, By the Inventor

Enter assignee name

Chicago, IL, United States of America

Biovec Transfusion, LLC

USPTO Granted Patents = 13

Forward Citations = 38

Loading Chart...

Loading Chart...

2 inventors (with patents filed for the assignee):

Lakshman R Sehgal (13 out of 27 patents)

Shaker Ahmed Mousa (4 out of 81 patents)

13 patents: Sort by Forward Citations

1. 9095818 - Method of filtering platelets to remove antiplatelet and anticoagulant agents (2015-08-04),

2. 8927203 - Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant (2015-01-06),

3. 8877060 - Methods for removing pathogens from a platelet preparation (2014-11-04),

4. 8715920 - Composition for preserving platelets during photosensitization (2014-05-06),

5. 8697347 - Composition for preserving platelets and method of using the same (2014-04-15),

6. 8470521 - Method for removing antiplatelet agent and anticoagulant from a platelet composition by diafiltration (2013-06-25),

7. 8431334 - Method for removing antiplatelet agent and anticoagulant from a platelet composition by diafiltration (2013-04-30),

8. 8329389 - Composition containing short-to-ultrashort GPIIb/IIIa and factor Xa inhibitors and platelets (2012-12-11),

9. 8232044 - Method of extending the shelf life of platelets using a composition comprising a short-to-ultrashort antiplatelet agent and anticoagulant and an oxygen carrier (2012-07-31),

10. 8142992 - Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier (2012-03-27),

11. 8129104 - Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobin (2012-03-06),

12. 8129103 - Use of a platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier (2012-03-06),

13. 7964338 - Platelet preservation composition containing eptifibatide, a reversible factor IIa inhibitor and a hemoglobin oxygen carrier (2011-06-21),

BIOVEC TRANSFUSION, LLC is a biotechnology company specialized in blood-based products, therapies, and research. With a focus on improving patient outcomes, we develop innovative solutions for transfusion medicine. Our team of experienced scientists and experts work tirelessly to advance the field of regenerative medicine using novel approaches and cutting-edge technologies. Through our research and product development, we aim to revolutionize the field of blood transfusions and contribute to the overall well-being of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

13 Patents

#265 in Chicago, IL

#1,146 in Illinois

#23,162 in US

#43,713 in the World

Chicago, IL, United States of America

Biovec Transfusion, LLC

Forward Citations = 38

2 inventors:

Lakshman R Sehgal (13 out of 27 patents)

Shaker Ahmed Mousa (4 out of 81 patents)

Please report any incorrect information to support@idiyas.com

Loading…